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Teratomas are the most frequently occurring germ cell tumors, with 45e65 percent occurring in the
sacrococcygeal region [1]. The case presented below involves a newborn male with a malignant sacro-
coccygeal teratoma and a number of congenital deformities including a left lower extremity amputation,
an absent left kidney, hypoplastic and absent left hemipelvis musculature. After excision of the teratoma
and subsequent chemotherapy treatment, the patient returned with a persistent abnormal soft tissue,
containing persistent malignant elements around the left femur, suspicious for a neuroendocrine tumor.
This case shows a rare association between two exceedingly uncommon malignancies.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Teratomas are the most frequently occurring germ cell tumors,
with 45e65 percent occurring in the sacrococcygeal region [1]. The
majority of sacrococcygeal teratomas (SCT’s) in neonates are benign
[2]. The case presented here involves a newborn male with a ma-
lignant sacrococcygeal teratoma and a number of congenital de-
formities; including a left lower extremity amputation, an absent
left kidney, hypoplasia of the left hemipelvis musculature, as well as
ambiguous genitalia. After excision of the teratoma and subsequent
chemotherapy, the patient returned with persistent abnormal soft
tissue containing malignant elements around the left femur. The
clinical presentation of this malignant sacrococcygeal teratoma and
its possible involvement in the congenital deformities present at
birth is a rare ﬁnding and one not seen in the current literature.1. Case report
A newborn male, gestational age 38.6 weeks and weighing
2.86 kg, was prenatally diagnosed with an apparent isolated amni-
otic band syndromewith amputation of the left lower extremity. At
birth, the infant was noted as having signiﬁcantly more congenital
anomalies than originally detected on prenatal ultrasound. There
was extensive involvement of the left lower portion of his body
including: Rectal prolapse, an absent left lower extremity, a biﬁdedical Center, Pediatric Sur-
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c. This is an open access article undepenus, and an absent hemiscrotum. Imaging, including a CT and an
MRI, identiﬁed an absent left kidney, a malpositioned bladder
directed toward the right, an absent left iliac bone, and a deformed,
partially absent hemisacrum. With the exception of a small femur,
the remainder of the left lower extremity was absent. The muscu-
lature of the left hemipelvis, including the gluteusmaximus/medius,
was profoundly hypoplastic. There was a scrotal sac seen anteriorly
above the subcutaneous tissues of the right pelvis containing a single
testicle, but no left hemiscrotum or left testicle. The imaging
demonstrated the physical exam ﬁndings of: rectal prolapse and
malformed phallus with perineal hypospadias, and a large area of
abnormal tissue around the left limb bud.
After complete imaging was obtained, the infant was taken to
the operating room for an exam under anesthesia with a diverting
colostomy and resection of the prolapsed rectum. During that time,
catheters were inserted into the urethra and rectum (Fig. 1). The
colostomy was performed and the prolapsed rectum was resected.
The perineum was sutured closed.
After resection, the pathology of the prolapsed rectum demon-
strated a malignant teratoma with areas of yolk sac/endodermal
sinus tumor as well as areas suggestive of embryonal carcinoma.
AFP and beta HCG levels were normal for age. Further work up at
this time revealed no evidence of metastatic disease. The patient
underwent three rounds of chemotherapy with follow up imaging
showing no residual disease.
One month following completion of chemotherapy, the
patient presented to the Emergency Department with anasarca,
tachypnea, tachycardia, and abnormalweight gain.Work up revealedr the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Intraoperative photo, day of life #5.
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severe hypertension and elevated urine metanephrines led to an
investigation for a pheochromocytoma or ACTH producing mass. An
MRI of his lower extremity was repeated after an MIBG failed to
localize a source (Fig. 2). A true cut biopsy of the abnormal appearing
tissue along the left femur lower was taken. This revealed small blue
cells andACTHproducing cellsversusextensionandmaturationof the
original teratoma. All pathology specimens were reviewed and
conﬁrmed by an outside pathologist, for this and the previousFig. 2. MRI of the pelvis at 1 day and 5 months showing increase in size of the lesion.specimens. A genetic workup undertaken during his hospital course
showed a normal karyotype and no known genetic associations.
Five days following the muscle biopsy he experienced severe
respiratory failure. His parents refused intubation and ultimately
withdrew care. Post mortem examination was refused by the par-
ents. He was ﬁve months old at the time of his death.
2. Discussion
Extragonadal germ cell tumors, including sacrococcygeal tera-
tomas, are thought to result from abnormal migration and depo-
sition of primordial germ cells [3]. The estimated incidence of
sacrococcygeal teratomas is 1 in 27,000 live births [2,4,5].
The classiﬁcation system for SCTs delineates four distinct types
based on anatomic presentation and intra-pelvic involvement, with
malignancy rates increasing with each type [6]. A yolk sac
component, which produces alpha fetoprotein (AFP), is the most
common malignant element [2,7,8]. As a result monitoring AFP
levels can be useful in detecting tumor recurrence.
Congenital anomalies are seen in 10e20 percent of cases
involving SCTs. Anomalies include tracheoesophageal ﬁstula,
imperforate anus, anorectal stenosis, spina biﬁda, genitourinary
malformations, meningomyelocele, and anencephaly [9,10].
Advances in both surgical treatment and the use of chemo-
therapy have resulted in signiﬁcant improvement in the overall
outcome with germ cell tumors. Studies have reported survival
rates ranging from 75% to 90% [11,12]. The standard chemotherapy
for malignant extragonadal SCTs includes a combination of
cisplatin, etoposide, and bleomycin (PEB) [13e15].
Neuroendocrine tumors such as a pheochromocytomas, have
never been reported in the literature in the setting of amalignant SCT.
As in our patient, most cases of pheochromocytomas or ACTH pro-
ducing tumors are diagnosed after histopathology [16]. Pheochro-
mocytomas only make up 3.5% of all malignant neuroendocrine
tumors, with patients younger than the age of 5 having amuch lower
chance of survival [17]. Less than 1% of all pediatric patients, aged 1
month to 18 years, are found to have a pheochromocytoma as the
etiology of hypertension. All these patients also had sustained
tachycardia, but those in this study did have elevated catecholamines
or their metabolites [18]. In the few reported cases of infants pre-
senting with Cushing Syndrome or its features, they have been asso-
ciated with adrenal tumors, or other neurological tumors [19,20].
Our patient’s case was a rare incidence in which a newborn boy
presented with a malignant teratoma and shortly thereafter a
neuroendocrine tumor. An association between SCTs and the host of
congential anomalies seen here, including those to the, limb and
pelvicmusculature, kidney, and other genitourinarymalformations,
have not been previously reported in the literature. Additionally,
SCT’s do not typically present with neuroendocrine components, or
in association with a de novo neuroendocrine tumor. Finally, this
casewas unique in that despite the tumor demonstratingmalignant
components within the SCTs, yolk sac and embryonal carcinoma,
bothB-HCGandAFPwere normal. This is a casewhere a patientwith
multiple phenotypical congenital anomalieswas likely the result of a
rare presentation of an even rarer combination of malignancies.
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